| |
Total population (n = 2247)
|
Lower GA (≤ 14.4%, n = 1133)
|
Higher GA (> 14.4%, n = 1114)
|
P value
|
|---|
|
Age, years
|
60.1 ± 9.0
|
58.2 ± 9.2
|
62.0 ± 8.3
|
< 0.001
|
|
Gender, male, n (%)
|
1616 (71.9)
|
864 (76.3)
|
752 (67.5)
|
< 0.001
|
|
BMI, kg/m2
|
26.1 ± 3.2
|
26.2 ± 3.2
|
26.0 ± 3.2
|
0.323
|
|
Heart rate, bpm
|
69.7 ± 10.2
|
68.9 ± 9.6
|
70.6 ± 10.6
|
< 0.001
|
|
SBP, mmHg
|
130.2 ± 16.5
|
128.9 ± 15.9
|
131.6 ± 16.9
|
< 0.001
|
|
DBP, mmHg
|
77.0 ± 9.8
|
77.3 ± 9.3
|
76.7 ± 10.2
|
0.162
|
|
Smoking history, n (%)
|
1280 (57.0)
|
714 (63.0)
|
566 (50.8)
|
< 0.001
|
|
Drinking history, n (%)
|
526 (23.4)
|
300 (26.5)
|
226 (20.3)
|
0.001
|
|
Family history of CAD, n (%)
|
233 (10.4)
|
120 (10.6)
|
113 (10.1)
|
0.728
|
|
Medical history, n (%)
|
|
T2DM
|
774 (34.4)
|
101 (4.5)
|
673 (30.0)
|
< 0.001
|
|
Hypertension
|
1397 (62.2)
|
671 (59.2)
|
726 (65.2)
|
0.004
|
|
Hyperlipidemia
|
1932 (86.0)
|
979 (86.4)
|
953 (85.5)
|
0.557
|
|
Anemia
|
33 (1.5)
|
8 (0.7)
|
25 (2.2)
|
0.002
|
|
Previous MI
|
473 (21.1)
|
220 (19.4)
|
253 (22.7)
|
0.056
|
|
Previous PCI
|
376 (16.7)
|
161 (14.2)
|
215 (19.3)
|
0.001
|
|
Previous stroke
|
259 (11.5)
|
113 (10.0)
|
146 (13.1)
|
0.020
|
|
Previous PAD
|
79 (3.5)
|
36 (3.2)
|
43 (3.9)
|
0.380
|
|
Clinical diagnosis, n (%)
|
|
UA
|
1873 (83.4)
|
951 (83.9)
|
922 (82.8)
|
0.456
|
|
NSTEMI
|
374 (16.6)
|
182 (16.1)
|
192 (17.2)
| |
|
Laboratory examinations
|
|
TG, mmol/L
|
1.5 (1.1, 2.1)
|
1.5 (1.1, 2.1)
|
1.4 (1.0, 2.1)
|
0.440
|
|
TC, mmol/L
|
4.1 ± 1.0
|
4.2 ± 1.0
|
4.1 ± 1.0
|
0.029
|
|
LDL-C, mmol/L
|
2.5 ± 0.9
|
2.5 ± 0.9
|
2.5 ± 0.8
|
0.022
|
|
HDL-C, mmol/L
|
1.0 ± 0.2
|
1.0 ± 0.2
|
1.0 ± 0.2
|
0.261
|
|
hs-CRP, mg/L
|
1.3 (0.6, 3.3)
|
1.2 (0.5, 2.9)
|
1.3 (0.6, 3.8)
|
0.006
|
|
Creatinine, μmol/L
|
75.8 ± 16.5
|
76.9 ± 16.7
|
74.7 ± 16.3
|
0.001
|
|
eGFR, mL/(min × 1.73 m2)
|
93.6 ± 20.0
|
93.7 ± 19.5
|
93.5 ± 20.5
|
0.790
|
|
Uric acid, μmol/L
|
344.1 ± 80.4
|
358.6 ± 79.5
|
329.5 ± 78.6
|
0.001
|
|
FBG, mmol/L
|
6.1 ± 1.9
|
5.3 ± 0.9
|
6.9 ± 2.3
|
< 0.001
|
|
HbA1c, %
|
6.3 ± 1.2
|
5.7 ± 0.5
|
6.9 ± 1.4
|
0.001
|
|
LVEF, %
|
64.0 ± 6.7
|
63.9 ± 7.0
|
64.0 ± 6.5
|
0.625
|
- GA glycated albumin, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, CAD coronary artery disease, T2DM type 2 diabetes mellitus, MI myocardial infarction, PCI percutaneous coronary intervention, PAD peripheral artery disease, UA unstable angina, NSTEMI non-ST-segment elevation myocardial infarction, TG triglyceride, TC total cholesterol, LDL-C low-density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, hs-CRP high-sensitivity C-reactive protein, eGFR estimated glomerular filtration rate, FBG fasting blood glucose, HbA1c glycosylated hemoglobin A1c, LVEF left ventricular ejection fraction
